摘要
金水宝胶囊可通过多靶点、多环节、多途径的形式协助机体改善新型冠状病毒肺炎后遗症状。通过分析相关文献,从抗炎、抗氧化、抑制破骨细胞活性、调节体内激素水平、改善肠道菌群等方面就其作用机制进行阐述,旨在指导临床治疗。
Jinshuibao capsule has been widely used in clinical study and basic experiment,it may help the body to improve sequelae of COVID-19 possibly through many targets,links and approaches,and to mitigate clinical symptoms by anti-inflammation,anti-oxidation,inhibiting the activity of osteoclast,regulating hormone levels in vivo and improving intestinal flora.In-vivo mechanism of Jinshuibao capsules in the treatment of COVID-19 at the recovery stage is analyzed,in order to guide clinical treatment.
作者
于海洋
秦忠
李文
刘怀全
陈云志
YU Haiyang;QIN Zhong;LI Wen;LIU Huaiquan;CHEN Yunzhi(Guizhou University of Chinese Medicine,Guiyang 550025,China)
出处
《西部中医药》
2022年第4期1-4,共4页
Western Journal of Traditional Chinese Medicine
基金
国家自然科学基金项目(81460694)
贵州省教育厅项目(黔教合KY字〔2017〕172,〔2017〕041)
第四批全国中医(临床、基础)优秀人才研修项目(国中医药人教发〔2017〕24号)。
